Compounders Research Compare

Prime Medicine, Inc.(PRME)

Biotechnology · Cambridge, MA

$3.48+0.27 (+8.31%)

Delayed quote: Oct 6, 2026, 2:00 PM EDT

About Prime Medicine, Inc.

Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor protein—a hybrid composed of a Cas protein and a reverse transcriptase enzyme—with a specialized pegRNA molecule. This pegRNA plays a crucial role by both guiding the Prime Editor to a precise location within the genome and providing the essential template for introducing the desired modification to the target DNA sequence. The company, founded in 2019, maintains its headquarters in Cambridge, Massachusetts.

Cambridge, MA

146 employees

www.primemedicine.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Allan Reine

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T18:04:56.321Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:04:56.321Z.

Quote observation: 2026-10-06T18:00:23.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -1.1
Quote price: 3.4768

FMP input reference: ed0d84ebe65fc765338e7baf7154c4548c52c7814b601df66b93f049f622236d

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

PRME Earnings Yield Metrics

EARNINGS YIELD

N/A

PRME Competitors' Earnings Yield

Prime Medicine, Inc.

Current

Market Cap

$627.97M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aura Biosciences, Inc.

Market Cap

$634.98M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SOPHiA GENETICS S.A.

Market Cap

$633.41M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OmniAb, Inc.

Market Cap

$638.60M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Climb Bio, Inc.

Market Cap

$615.86M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Starling Oncology, Inc.

Market Cap

$657.49M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Ironwood Pharmaceuticals, Inc.

Market Cap

$600.59M

Earnings Yield

21.03%

TTM Avg

9.68%

3Y Avg

7.09%

5Y Avg

13.06%

AngioDynamics, Inc.

Market Cap

$597.67M

Earnings Yield

N/A

TTM Avg

2.32%

3Y Avg

2.32%

5Y Avg

1.62%

ArriVent BioPharma, Inc.

Market Cap

$677.67M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Annexon, Inc.

Market Cap

$664.38M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Prime Medicine, Inc. (PRME)	$627.97M	N/A	N/A	N/A	N/A
Aura Biosciences, Inc. (AURA)vs ›	$634.98M	N/A	N/A	N/A	N/A
SOPHiA GENETICS S.A. (SOPH)vs ›	$633.41M	N/A	N/A	N/A	N/A
OmniAb, Inc. (OABI)vs ›	$638.60M	N/A	N/A	N/A	N/A
Climb Bio, Inc. (CLYM)vs ›	$615.86M	N/A	N/A	N/A	N/A
Starling Oncology, Inc. (STLN)vs ›	$657.49M	N/A	N/A	N/A	N/A
Ironwood Pharmaceuticals, Inc. (IRWD)vs ›	$600.59M	21.03%	9.68%	7.09%	13.06%
AngioDynamics, Inc. (ANGO)vs ›	$597.67M	N/A	2.32%	2.32%	1.62%
ArriVent BioPharma, Inc. (AVBP)vs ›	$677.67M	N/A	N/A	N/A	N/A
Annexon, Inc. (ANNX)vs ›	$664.38M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics